Funded by: National Institute of Health
Principle Investigator: Gabriel Dichter, PhD
Co-Investigators: Jim Bodfish & Linn Sikich
Project Coordinator: Jennifer Felder, BS

Brain Imaging Study Without Medication:

This study uses fMRI technology to study brain activity in people with high functioning autism. Individuals not interested in medication have the option of participating in one 90 minute brain scan.

Eligibility: We are looking for individuals 18 - 55 years old who are diagnosed with High Functioning Autism.
Reimbursement: $35-45 for scan session, $10/hour for other study appointments (assessments and screening).

fMRI Evaluation of the Effect of Citalopram in People With Autism:

We are using fMRI technology to investigate how a medication called Citalopram (also known as Celexa©) reduces repetitive behaviors in people diagnosed with Autism. Results may help us understand how this medication works and may ultimately help to develop new interventions.

Participation: This study lasts 12 weeks and participation involves a diagnostic evaluation at the UNC Autism Center in Carrboro, up to 6 appointments at the UNC-Chapel Hill Neurosciences Hospital for medication check-in appointments with a pediatric psychiatrist and standard paper-and-pencil evaluations of symptoms, and two fMRI brain scans at Duke Medical Center.

Reimbursement: Participants will be reimbursed up to $50 for each scan session as well as $10/hour for all other screening and study appointments.